Fibrosis is a complex process involving an inflammatory reaction, fibroblast proliferation, and abnormal accumulation of interstitial collagens. Mononuclear
Introduction
The interstitial lung diseases (ILD)' are a heterogeneous group of diffuse inflammatory disorders that affect the pulmonary parenchyma (1) (2) (3) . Idiopathic pulmonary fibrosis (IPF) is one 1 . Abbreviations used in this paper: ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; PDGF, platelet-derived growth factor. of the major ILDs of unknown origin. It is characterized by an increase in the number ofinflammatory cells and a progressive alteration of the alveolo-capillary units by a fibrotic process.
This process consists ofan increase in fibroblast population (2, 3) , and an excessive accumulation of interstitial collagens (4) , which results in disruption of the gas exchange units causing progressive respiratory failure.
The processes mediating the proliferation of fibroblasts and increased collagen synthesis within the alveolar structures are not completely understood. In vitro studies have demonstrated that cultured alveolar macrophages obtained from patients with interstitial lung fibrosis release several growth factors (5, 6 ) including platelet-derived growth factor (PDGF) (7, 8) . PDGF is a potent mitogen and chemoattractant for fibroblasts and smooth muscle cells and a stimulator of collagen synthesis by fibroblasts. It is normally transported in blood, stored in the alpha-granules of platelets. Human PDGF contains two polypeptide chains (PDGF-1 and PDGF-2) linked together by disulfide bonds (9) . The PDGF-2, or PDGF-B, chain is encoded by the c-sis/protooncogene localized in chromosome 22, and the PDGF-1, or PDGF-A, chain is encoded by a gene localized in chromosome 7 (for review see reference 10). Activated monocytes and macrophages were shown to express the c-sis/PDGF-2 protooncogene and to synthesize and secrete PDGF-like mitogen (7, 8, 1 1) . Monocytes/macrophages are invariably increased in ILD, and it is possible that production of PDGF by these cells contributes to the progression of fibrosis and interstitial collagen accumulation. Support for this possibility has been provided by studies demonstrating that alveolar macrophages obtained from IPF patients express the c-sis/PDGF-2 gene and release PDGF-like mitogen (12) . The present studies provide the first direct evidence for the expression of the c-sis protooncogene by human lung tissue obtained from patients with IPF. In situ hybridization has localized the c-sis mRNA both in macrophages and epithelial cells of the fibrotic tissue. Production of PDGF-like proteins was also localized in the macrophages and epithelial cells of patients with IPF but not in normal lung tissue. These studies suggest the possibility that the production of PDGF-like mitogen by epithelial cells and macrophages in lung tissue may be part of the mechanisms contributing to fibrosis and increased collagen deposition, both characteristics of human pulmonary fibrosis.
Methods
Tissue collection. Pulmonary specimens from five patients with IPF were collected by open lung biopsy. The patients were hospitalized in the National Institute of Respiratory Diseases, Mexico City, Mexico. They exhibited a typical clinical, radiographic, and respiratory functional picture, characterized by a progressive dyspnea, diffuse reticulonodular pattern on chest x ray, and a restrictive ventilatory defect with hypoxemia at rest that worsened with exercise. The definitive diagnosis was made by the morphological study of tissue samples ob-tained through open lung biopsy. Biopsies were performed after careful evaluation by the local medical/surgical committee for confirmation of diagnosis and for aiding the course of treatment. Control lung specimens were obtained from individuals undergoing lobectomy or wedge resection for removal of a primary lung tumor. The tissue sections used in these studies were free of pathologic evidence for malignancy.
In the present studies, we examined five lung specimens from patients with IPF In situ hybridization combined with immunocytochemistry. To identify the cells expressing the c-sis/PDGF-2 protooncogene, we stained the tissues with markers specific for epithelial cells and macrophages after hybridization, and then counterstained with hematoxylin. For this combined step the dextran sulfate was deleted from the hybridization buffer to avoid background staining during immunocytochemistry. For epithelial cells, the tissue was stained with a polyclonal antibody to bovine antikeratin (Sigma Chemical Co.), and for monocytes/macrophages with the HAM56 monoclonal antibody which also reacts with capillary endothelial cells (17). For the staining studies, after hybridization the tissues were washed with PBS, endogenous peroxidase activity was suppressed with 0.3% H202 in methanol, and reacted with the appropriate antibody using the Vectastain ABC kit (Vector Laboratories, Inc., Burlingame, CA). The tissues were then dehydrated and dipped in NT-B2 emulsion (Kodak Laboratory and Specialty Chemicals), and processed as described.
In situ hybridization combined with immunostaining for PDGFlike proteins. For the detection of PDGF-like proteins in lung tissue from patients with IPF, in situ hybridization was combined with staining with rabbit polyclonal PDGF antisera raised against pure human PDGF (10). These antisera recognize the PDGF heterodimer and both the PDGF-I and PDGF-2 homodimers. The procedures for this study are identical to those described above for the combined steps of in situ hybridization and immunocytochemistry. The specificity of the reaction with the PDGF antisera was tested by control studies based on the preincubation of the antisera with excess (50 jig) of purified human PDGF or recombinant c-sis/PDGF-2 homodimer (Institute of Molecular Biology, Boston, MA).
Results
Expression of the c-sis/PDGF-2 protooncogene by lung tissue ofpatients with IPF. RNA samples derived from lung tissue of a patient with IPF and from control lung tissue without IPF were subjected to Northern blot analysis. As shown in Fig. 1 f3-actin probe to establish that differences in c-sis protooncogene expression were not due to differences in the amount of RNA used in the individual samples. In a separate study shown in Fig. 1 B, we examined the expression of the c-sis protooncogene in three additional specimens of lung tissue with IPF (lanes 2-4). The small size of the tissue specimens available for this study yielded smaller amounts of RNA for Northern blot analysis. However, all of these specimens ex- To identify the cells of origin in the tissue expressing the c-sis protooncogene, we proceeded with the following studies using in situ hybridization.
Localization ofthe c-sis/PDGF-2 mRNA in epithelial cells and macrophages ofIPF lung tissue. In situ hybridization was combined with immunocytochemistry using specific antibodies for epithelial cells (anti-keratin antibody) and for macrophages (HAM56 antibody). Fig. 2 demonstrates the strong expression of c-sis mRNA in the stained epithelial cells of lung tissue from a patient with IPF. Fig. 2 A represents a 630 magnification, and Fig. 2 , B and C, represents an expanded magnification of 1,000. The data shown in Fig. 2 are representative ofthe data obtained in the tissue sections derived from the five lung specimens with IPF examined. The specificity of the hybridization data shown in Fig. 2 was tested by hybridization of the fibrotic lung sections with control noncomplementary "sense" RNA probe for c-sis. As shown in Fig. 3 A, hybridization with complementary "antisense" probe produced a strong expression of c-sis mRNA in the stained epithelial cells of the fibrotic tissue. Hybridization with noncomplementary "sense" probe did not produce a significant signal (Fig. 3 B) . In Figs. 2 and 3 A, the autoradiographic grains were localized in the stained epithelial cells of the alveolar septal surface as shown by light microscopy. The stained epithelial cells on the septal surface can be seen more clearly in the control section of Fig. 3 B, in the absence of distortion caused by the path length of 35S used for the labeling ofthe cRNA probe, and in Fig. 6 A, where the epithelial cells were counterstained only with hematoxylin. In contrast to the results obtained in IPF tissues, the four normal lung tissues without IPF did not express c-sis mRNA. The magnification in Fig. 4 A is 400, and B is 1,000. Notice the lack of expression of c-sis mRNA in the control lung tissue without IPF.
As shown in Fig. 4 , there is no evidence for c-sis mRNA expression in the stained epithelial cells of the control tissue without IPF.
Invading macrophages in IPF lung tissue also expressed c-sis mRNA. This is demonstrated in Fig. 5 , which represents a combined in situ hybridization for c-sis mRNA and immunostaining for macrophages. A weak expression of c-sis mRNA was also observed in the capillary endothelial cells that were stained with the HAM56 antibody (Fig. 5 B) . The expression of c-sis mRNA in macrophages is further demonstrated in Fig. 6 . A strong expression of c-sis mRNA can be seen in both epithelial cells and stained alveolar macrophages (Fig. 6 A) . Clusters of macrophages infiltrating the fibrotic tissue also expressed c-sis mRNA (Fig. 6 , B and C). Control hybridization with noncomplementary probe did not produce a significant signal in the stained macrophages (Fig. 6 D) . The in situ hybridization studies described above demonstrated the expression of c-sis mRNA in both epithelial cells and macrophages in IPF lung tissue. Capillary endothelial cells in these studies showed much less hybridization. Detection ofPDGF-like proteins in lung tissue ofpatients with IPF. The expression of c-sis mRNA in the lung tissue sections of patients with IPF was accompanied by the expression of PDGF-like proteins as shown by immunocytochemistry using specific PDGF antisera. In contrast, control nonfibrotic lung tissue did not express PDGF-like proteins. As shown in Fig. 7 A, there is a strong expression of PDGF-like proteins in fibrotic tissue stained with PDGF antisera. The specificity of this immunostaining reaction was tested by neutralizing the PDGF antisera with excess purified human PDGF or recombinant c-sis/PDGF-2 homodimer. Fig. 7 B shows that there is no immunostaining when the PDGF antisera were preincubated with excess (50 ng) purified PDGF. Similar results were obtained when the PDGF antisera were preincu- bated with excess recombinant PDGF (data submitted, not shown). Control nonfibrotic tissue did not express PDGF-like proteins when it was immunostained with the PDGF antisera (Fig. 7 C) . This is consistent with the lack ofexpression ofc-sis mRNA in the control nonfibrotic tissues. Fig. 7 D shows the focal co-expression of c-sis mRNA and PDGF-like proteins in a lung section ofa patient with IPF. In this study we combined in situ hybridization for c-sis mRNA with immunostaining with PDGF antisera. As discussed by Hoffiler et al. (18), this combined procedure tends to enhance the intensity of the immunostaining and weaken the intensity of mRNA detection because of the added steps in this combined process.
Discussion
The present data provide the first direct evidence for the in vivo expression of the c-sis/PDGF-2 protooncogene in lung tissue derived from patients with idiopathic lung fibrosis (IPF). Lung tissue without IPF did not express the c-sis protooncogene. In situ hybridization studies demonstrated a strong expression of c-sis mRNA in epithelial cells and in macrophages and to a lesser extent in the capillary endothelial cells in the tissues from patients with IPF. Immunostaining with PDGFantisera detected PDGF-like proteins in lung tissue from patients with IPF but not in control nonfibrotic lung tissue. Furthermore, combined in situ hybridization and immunostaining with PDGF antisera demonstrated the co-expression of c-sis mRNA and PDGF-like proteins in the lung tissues of patients. The alveolar epithelial cells were the primary cells expressing c-sis mRNA and PDGF-like proteins. The in situ hybridization data for c-sis mRNA and the immunostaining data for PDGF-like proteins reported in this manuscript were uniform and reproducible in all sections derived from the five lung biopsies of patients. 1060 Antoniades, Bravo, Avila, Galanopoulos, Neville-Golden, Maxwell, and Selman Previous studies have shown that cultured activated macrophages express the c-sis protooncogene and produce PDGFlike mitogen (7, 8 (Fig. 7 C) .
Fibrosis and excessive collagen synthesis are events associated with IPF. The unregulated local production of PDGF may contribute to the expansion of connective tissue cells and collagen accumulation in lung parenchymal, because PDGF is a potent chemoattractant and mitogen for fibroblasts and smooth muscle cells (27-29) and a stimulator of collagen synthesis by fibroblasts. An increase in the number of fibroblasts within the alveolar structures, which has been demonstrated in both animals and humans with chronic interstitial lung disease (30, 31) , is critical in the pathogenesis oflung fibrosis. Furthermore, PDGF can stimulate the production of collagenase (32) in fibroblasts, which may explain the progressive derangement in interstitial collagens at least in the initial phases of the disease. In this context, the presence of active collagenase within the lower respiratory tract can be responsible for ultrastructural alterations described in patients with IPF like the fragmentation and fraying of the collagen fibers in the lung interstitium (33).
The important new finding in these studies is the recognition of a strong expression of c-sis/PDGF-2 mRNA in the epithelial cells of lung tissue derived from patients with IPF. This "inappropriate" expression may be an important contributing factor in the development of fibrosis. The local constitutive production of PDGF-like mitogen by the epithelial cells, could serve for the paracrine recruitment and stimulation of target cells such as fibroblasts and smooth muscle cells, and to an exaggerated production and accumulation of interstitial collagens in patients with IPF.
The initial events leading to IPF are not known. Injury is considered to be among the causes ofthe disease. Recent studies have shown that acute injury in animals induces the reversible expression of the c-sis and PDGF receptor b mRNAs in the epithelial cells of the injured tissue (Antoniades, H. N., et al., submitted for publication). Normal epithelial cells do not express c-sis and PDGF receptor mRNAs. The expression of the mRNAs in the epithelial cells occurred within 1 d of injury and it was suppressed by day five, which coincides with the time of reepithelialization of the injured tissue. These findings provide direct evidence that acute injury can induce a reversible expression of protooncogenes in the epithelium. It is conceivable that "chronic" injury can cause an irreversible, inappropriate gene expression, like the expression of the c-sis protooncogene in the lung epithelium of patients with IPF described in the present studies.
